Propanc Biopharma, Inc.

Propanc Biopharma, Inc. - Enterprise Valueverified

PPCB

Price:

$0.99

Market Cap:

$865.63K

Propanc Biopharma, Inc. (PPCB) is an Australian biopharmaceutical firm dedicated to developing innovative treatments for various cancers, with a particular focus on pancreatic, ovarian, and colorectal malignancies. The company's leading therapeutic candidate, PRP, is a unique formulation currently in the preclinical stage of development. This product is designed to enhance the effectiveness of multiple enzymes that work together to combat cancer. Propanc Biopharma is also engaged in a collaborative research effort with the University of Jaén, initiating the POP1 joint drug discovery program. Founded in 2007, the entity was originally known as Propanc Health Group Corporation before officiall...[Read more]

Industry

Biotechnology

IPO Date

2012-11-12

Stock Exchange

NASDAQ

Ticker

PPCB

The Enterprise Value as of July 2026 (TTM) for Propanc Biopharma, Inc. (PPCB) is 2.00M

According to Propanc Biopharma, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 2.00M. This represents a change of -90.23% compared to the average of 20.43M of the last 4 quarters.

Propanc Biopharma, Inc. (PPCB) Historical Enterprise Value (quarterly & annually)

How has PPCB Enterprise Value performed in the past?

The mean historical Enterprise Value of Propanc Biopharma, Inc. over the last ten years is 18215.67T. The current 2.00M Enterprise Value has changed -100.00% with respect to the historical average. Over the past ten years (40 quarters), PPCB's Enterprise Value was at its highest in in the September 2016 quarter at 211778.24T. The Enterprise Value was at its lowest in in the September 2023 quarter at 1.04M.

Quarterly (TTM)
Annual

Average

18215.67T

Median

1.59M

Minimum

991.34K

Maximum

182156.69T

Propanc Biopharma, Inc. (PPCB) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Propanc Biopharma, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 1.65%

Maximum Annual Enterprise Value = 182156.69T

Minimum Annual Increase = -100.00%

Minimum Annual Enterprise Value = 991.34K

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202518.18M1.65%
20241.04M-22.90%
20231.35M29.85%
20221.04M4.55%
2021991.34K-39.10%
20201.63M4.67%
20191.56M-65.67%
20184.53M36.18%
20173.33M-100.00%
2016182156.69T-42.97%

Propanc Biopharma, Inc. (PPCB) Average Enterprise Value

How has PPCB Enterprise Value performed in the past?

The current Enterprise Value of Propanc Biopharma, Inc. (PPCB) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

6.86M

5-year avg

4.52M

10-year avg

18215.67T

Propanc Biopharma, Inc. (PPCB) Enterprise Value vs. Peers

How is PPCB’s Enterprise Value compared to its peers?

Propanc Biopharma, Inc.’s Enterprise Value is less than Quest PharmaTech Inc. (5.74M), less than Gemina Laboratories Ltd. (4.83M), less than Telescope Innovations Corp. (35.32M), less than PreveCeutical Medical Inc. (13.64M), greater than Synairgen plc (1.06M), less than EOM Pharmaceuticals Holdings, Inc. (18.17M), less than Cell Source, Inc. (49.60M), less than Zenith Capital Corp. (7.99M), greater than HOOKIPA Pharma Inc. (-19288217.00), less than Sirona Biochem Corp. (3.91M),

Build a custom stock screener for Propanc Biopharma, Inc. (PPCB) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Propanc Biopharma, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Propanc Biopharma, Inc. (PPCB) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Propanc Biopharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Propanc Biopharma, Inc.'s Enterprise Value?

What is the highest Enterprise Value for Propanc Biopharma, Inc. (PPCB)?

What is the 3-year average Enterprise Value for Propanc Biopharma, Inc. (PPCB)?

What is the 5-year average Enterprise Value for Propanc Biopharma, Inc. (PPCB)?

How does the current Enterprise Value for Propanc Biopharma, Inc. (PPCB) compare to its historical average?